Press release
Cardiac Marker Market Research Reveals Strong 12.9% CAGR Outlook Through 2030
Cardiac Marker Market
Projected Size and Growth of the Cardiac Marker Market by 2030
The cardiac marker market is predicted to grow swiftly, reaching a valuation of $22.7 billion by 2030. This represents a compound annual growth rate (CAGR) of 12.9% over the forecast period. The expansion is primarily fueled by growing demand for faster diagnostic turnaround times, the rising integration of cardiac diagnostic tools with digital platforms, and the broader availability of point-of-care testing facilities. Additionally, the increasing use of advanced biomarker panels and a heightened focus on precision cardiology are key contributors to this growth. Notable trends shaping the market include a shift toward high-specificity cardiac marker panels, greater adoption of automated immunoassay systems, rising demand for rapid cardiac diagnosis, expansion of multiparametric testing techniques, and an enhanced emphasis on clinical decision support systems.
Download a free sample of the cardiac marker market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Key Players Leading the Cardiac Marker Market
Several prominent companies dominate the cardiac marker market landscape. These include Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, and Creative Diagnostics.
A notable development occurred in April 2023 when Abbott Laboratories acquired Cardiovascular Systems Inc., a US-based medical technology company. This strategic acquisition allows Abbott to enhance its offerings for patients suffering from peripheral and coronary artery diseases by providing innovative and advanced therapies for complex cardiovascular conditions. The move also expands Abbott's portfolio of cutting-edge vascular devices, equipping healthcare providers with better tools to support patient care.
Emerging Innovations Shaping Cardiac Marker Market Trends
Focusing on product innovation, many leading companies are investing in advanced cardiac biomarkers like high-sensitivity troponin I (hs-cTnI) and NT-proBNP to boost their market presence. These biomarkers play a crucial role in diagnosing, classifying, and managing cardiovascular diseases.
For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a Chinese medical equipment manufacturer and distributor, introduced hs-cTnI and NT-proBNP cardiac biomarkers. The newly launched hs-cTn assay exceeds the minimal sensitivity, accuracy, and reliability standards required for detecting myocardial damage. These innovations aim to provide dependable diagnostic tools that improve patient outcomes, supporting better management of cardiovascular illnesses both within and beyond the cardiology field.
View the full cardiac marker market report:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Detailed Segmentation of the Global Cardiac Marker Market
The global cardiac marker market can be categorized according to several key segments:
1) Biomarker Type: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, and Other Biomarkers
2) Product Type: Reagents, Instruments, Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA
3) Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Other Indications
4) End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-of-Care Testing Facilities, and Academic Institutions
Further subdivisions include:
- Troponin: Troponin I, Troponin T, and Troponin Diagnostic Kits
- Creatine Kinase-MB (CK-MB): CK-MB Test Kits and Diagnostic Panels
- B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, and Diagnostic Panels
- Myoglobin: Test Kits and Diagnostic Panels
- Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), and C-Reactive Protein (CRP)
This detailed categorization helps stakeholders understand the diverse product offerings and applications within the cardiac marker market, supporting targeted strategies and innovation.
Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Marker Market Research Reveals Strong 12.9% CAGR Outlook Through 2030 here
News-ID: 4569428 • Views: …
More Releases from The Business Research Company
Cardiovascular Medical Lasers Market Report Evaluates Growth Drivers, Challenges …
The cardiovascular medical lasers market is poised for remarkable expansion as advancements in cardiac care continue to accelerate. With rising demand for cutting-edge treatments and increasing adoption of laser technologies in cardiovascular procedures, this industry is set to witness significant growth through 2030.
Cardiovascular Medical Lasers Market Size and Growth Outlook
The cardiovascular medical lasers market is forecast to surge dramatically, reaching a valuation of $2.31 billion by 2030. This…
Defibrillator Devices And Equipment Market Research Reveals Strong 6.3% CAGR Out …
The defibrillator devices and equipment market is set for significant expansion in the coming years, driven by advancements in technology and increased adoption of cardiac care solutions. This growing market is responding to rising healthcare demands and innovations that are making life-saving interventions more accessible and effective. Below is an overview of the market's size, key players, important trends, and segmentation details shaping its future.
Projected Market Value and Growth Prospects…
Cardiovascular Devices Market Report Provides Insights Into Market Evolution And …
The cardiovascular devices market is on a promising growth trajectory, driven by technological breakthroughs and increasing demand for advanced cardiac care solutions. As healthcare providers continue to prioritize improved patient outcomes, the market is set to experience substantial expansion through 2030. Below is an overview of the market's size, key players, evolving trends, and segmentation details.
Projected Growth Outlook for the Cardiovascular Devices Market Through 2030
The cardiovascular devices market…
Declotting Devices Market Intelligence Report Covers Trends, Segments And Region …
A Closer Look at the Declotting Devices Market and Its Future Outlook
The declotting devices industry is on track for substantial expansion in the coming years, driven by rising health concerns and technological progress. With the increasing number of cardiovascular and thrombotic conditions worldwide, along with advancements in medical procedures, this market is poised to witness steady growth through 2030. Let's examine the market's expected value, the main players…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
